Livraison gratuite et discrète dès 200 € - qualité testée en laboratoire

LabGain
Tirsepatide Tirsepatide (6 mg) PeptideSciences
oxyPharma

Tirsepatide Tirsepatide (6 mg) PeptideSciences

0 avis clients
Prix sur demande

Tirzepatide 6 mg: an innovative approach to treating type 2 diabetes and weight loss Tirzepatide 6 mg is a unique solution for patients seeking not only to improve blood sugar control, but also to manage body weight. This drug is developed for the treatment of type 2 diabetes and is based on the dual action of glucagon-like peptide-1 (GLP-1) and glucose-dependent insulinotropic polypeptide (GIP) analogues. Both hormones regulate glucose levels and appetite, making tirzepatide a promising treatme

● Rupture de stock
1
  • Référence: tirsepatide-tirsepatide-6-mg-peptidesciences-default
  • Marque: oxyPharma
  • Catégorie: Peptides

Tirzepatide is a dual GIP/GLP-1 receptor agonist that combines the action of two incretin hormones in a single peptide. By stimulating insulin secretion after meals and suppressing glucagon secretion between meals, it supports both post-meal and fasting blood sugar stability while also acting on appetite centers to reduce hunger. This PeptideSciences vial contains 6 mg of Tirzepatide, a practical size for the earlier stages of titration.

This dual mechanism gives Tirzepatide a stronger overall metabolic effect than single-pathway peptides, supporting significant, gradual weight loss alongside improved glycemic control and cardiovascular support.

Key Benefits

  • Dual GIP/GLP-1 action for stronger glycemic and appetite control than single-receptor peptides
  • Suppresses appetite and increases satiety, supporting gradual weight loss
  • Stabilizes blood glucose both after meals and between meals
  • Supports cardiovascular health markers relevant to metabolic patients
  • 6 mg vial size suits users in the early-to-mid titration phase

Avis (0)

Aucun avis pour le moment.

Rédiger un avis

Votre note

Produits similaires